Latest Close
$21.10
News
ACAD
ACADIA Pharmaceuticals Inc. News
This news view pulls recent coverage and headlines tied to ACAD.
1y Change
-$0.88 (-4.00%)
Market Cap
$3.61B
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth
MarketBeat • May 19, 2026
Read articleShareholders In ACADIA Pharmaceuticals (NASDAQ:ACAD) Should Look Beyond Earnings For The Full Story
Simply Wall St. • May 14, 2026
Read articleACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms
MarketBeat • May 13, 2026
Read articleEarnings Miss: ACADIA Pharmaceuticals Inc. Missed EPS By 58% And Analysts Are Revising Their Forecasts
Simply Wall St. • May 11, 2026
Read articleWhat ACADIA Pharmaceuticals (ACAD)'s Earnings Miss, EU Setback and R&D Transition Means For Shareholders
Simply Wall St. • May 9, 2026
Read articleEarnings To Watch: AcadeMedia AB (OSTO:ACAD) Reports Q3 2026 Result
GuruFocus.com • May 8, 2026
Read article